The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Endothelial Ca2+‐activated K+channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery
Open accessAbstract
The arterial endothelium critically contributes to blood pressure control by releasing vasodilating autacoids such as nitric oxide, prostacyclin and a third factor or pathway termed ‘endothelium‐derived hyperpolarizing factor’ (EDHF). The nature of EDHF and EDHF‐signalling pathways is not fully understood yet. However, endothelial hyperpolarization mediated by the Ca 2+‐activated K+channels (K Ca) has been suggested to play a critical role in initializing EDHF–dilator responses in conduit and resistance‐sized arteries of many species including humans. Endothelial K Ca currents are mediated by the two K Ca subtypes, intermediate‐conductance K Ca(KCa3.1) (also known as, a.k.a. IK Ca) and small‐conductance K Ca type 3 (KCa2.3) (a.k.a. SK Ca). In this review, we summarize current knowledge about endothelial KCa3.1 and KCa2.3 channels, their molecular and pharmacological properties and their specific roles in endothelial function and, particularly, in the EDHF–dilator response. In addition we focus on recent experimental evidences derived from KCa3.1‐ and/or KCa2.3‐deficient mice that exhibit severe defects in EDHF signalling and elevated blood pressures, thus highlighting the importance of the KCa3.1/KCa2.3‐EDHF–dilator system for blood pressure control. Moreover, we outline differential and overlapping roles of KCa3.1 and KCa2.3 for EDHF signalling as well as for nitric oxide synthesis and discuss recent evidence for a heterogeneous (sub) cellular distribution of KCa3.1 (at endothelial projections towards the smooth muscle) and KCa2.3 (at inter‐endothelial borders and caveolae), which may explain their distinct roles for endothelial function. Finally, we summarize the interrelations of altered KCa3.1/KCa2.3 and EDHF system impairments with cardiovascular disease states such as hypertension, diabetes, dyslipidemia and atherosclerosis and discuss the therapeutic potential of KCa3.1/KCa2.3 openers as novel types of blood pressure‐lowering drugs. British Journal of Pharmacology(2009)157,509–526; doi:10.1111/j.1476‐5381.2009.00132.x; published online 19 March 2009 This article is part of a themed section on Endothelium in Pharmacology. For a list of all articles in this section see the end of this paper, or visit:http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2009
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · cited 1×
“This endothelium-derived relaxing factor turned out to be the gas nitric oxide (NO) (Furchgott and Zawadzki, 1980; Palmer et al., 1987).”
BackgroundHypertension in mice lacking the gene for endothelial nitric oxide synthase
Huang, P. L., Huang, Z., Mashimo, H., Bloch, K. D., Moskowitz, M. A., Bevan, J. A., & Fishman, M. C. (1995) · Nature · doi:10.1038/377239a0 · Cited by 2,070
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957 · cited 1×
“…there is growing evidence that this endothelial dysfunction is not only related to diminished NO production or NO availability (for review also see Forstermann and Munzel, 2006; Taddei et al., 2006b), but in some disease states also to defects in the EDHF system(s) [for review see (Feletou and…”
BackgroundGuide to receptors and channels (GRAC), 5th edition
Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947
Endemann, D. H., & Schiffrin, E. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132474.50966.da · Cited by 1,198
Cited by
Endothelial dysfunction — A major mediator of diabetic vascular disease
Sena, C. M., Pereira, A. M., & Seiça, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.08.006 · Cited by 797
Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs
Cirino, G., Szabo, C., & Papapetropoulos, A. (2023) · Physiological Reviews · doi:10.1152/physrev.00028.2021 · Cited by 553
GPR68 Senses Flow and Is Essential for Vascular Physiology
Xu, J., Mathur, J., Vessières, E., Hammack, S., Nonomura, K., Favre, J., Grimaud, L., Petrus, M., Francisco, A., Li, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.076 · Cited by 311
Rangaraju, S., Raza, S. A., Pennati, A., Deng, Q., Dammer, E. B., Duong, D., Pennington, M. W., Tansey, M. G., Lah, J. J., Betarbet, R., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0906-6 · Cited by 75
Metadata
- Authors
- Grgic, I., Kaistha, B. P., Hoyer, J., & Köhler, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2009-06
- Volume
- 157
- Issue
- 4
- Pages
- 509-526
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1489379070
- Cited by
- 193
- References
- 5
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Endothelial Ca2+‐activated K+channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00132.x
- The paper
- Grgic, I., Kaistha, B. P., Hoyer, J., & Köhler, R. (2009). Endothelial Ca2+‐activated K+channels in normal and impaired EDHF–dilator responses – relevance to cardiovascular pathologies and drug discovery. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00132.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.